Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

VSEEW vs WELL vs VTR vs TDOC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VSEEW
VSee Health, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$545K
5Y Perf.-85.2%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$150.37B
5Y Perf.+105.9%
VTR
Ventas, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$41.50B
5Y Perf.+70.3%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.31B
5Y Perf.-25.9%

VSEEW vs WELL vs VTR vs TDOC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VSEEW logoVSEEW
WELL logoWELL
VTR logoVTR
TDOC logoTDOC
IndustryMedical - Healthcare Information ServicesREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesMedical - Healthcare Information Services
Market Cap$545K$150.37B$41.50B$1.31B
Revenue (TTM)$15M$11.63B$6.13B$2.51B
Net Income (TTM)$-12M$1.43B$260M$-171M
Gross Margin54.6%39.1%-4.3%65.6%
Operating Margin-65.1%4.4%13.4%-7.6%
Forward P/E79.6x119.0x
Total Debt$10M$21.38B$13.22B$1.04B
Cash & Equiv.$326K$5.03B$741M$781M

VSEEW vs WELL vs VTR vs TDOCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VSEEW
WELL
VTR
TDOC
StockJun 24May 26Return
VSee Health, Inc. (VSEEW)10014.8-85.2%
Welltower Inc. (WELL)100205.9+105.9%
Ventas, Inc. (VTR)100170.3+70.3%
Teladoc Health, Inc. (TDOC)10074.1-25.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: VSEEW vs WELL vs VTR vs TDOC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WELL leads in 6 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. VSee Health, Inc. is the stronger pick specifically for growth and revenue expansion. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
VSEEW
VSee Health, Inc.
The Growth Play

VSEEW is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 78.4%, EPS growth -5.7%, 3Y rev CAGR 12.4%
  • 78.4% revenue growth vs TDOC's -1.5%
Best for: growth exposure
WELL
Welltower Inc.
The Real Estate Income Play

WELL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 0.15, yield 1.3%
  • 225.2% 10Y total return vs VTR's 66.1%
  • Lower volatility, beta 0.15, Low D/E 49.5%, current ratio 5.34x
  • Beta 0.15, yield 1.3%, current ratio 5.34x
Best for: income & stability and long-term compounding
VTR
Ventas, Inc.
The REIT Holding

VTR plays a supporting role in this comparison — it may shine differently against other peers.

Best for: real estate exposure
TDOC
Teladoc Health, Inc.
The Secondary Option

TDOC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthVSEEW logoVSEEW78.4% revenue growth vs TDOC's -1.5%
ValueWELL logoWELLLower P/E (79.6x vs 119.0x)
Quality / MarginsWELL logoWELL12.3% margin vs VSEEW's -85.8%
Stability / SafetyWELL logoWELLBeta 0.15 vs TDOC's 1.89, lower leverage
DividendsWELL logoWELL1.3% yield, 2-year raise streak, vs VTR's 2.1%, (2 stocks pay no dividend)
Momentum (1Y)WELL logoWELL+46.7% vs VSEEW's -8.8%
Efficiency (ROA)WELL logoWELL2.3% ROA vs VSEEW's -66.7%, ROIC 0.5% vs -15.0%

VSEEW vs WELL vs VTR vs TDOC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VSEEWVSee Health, Inc.
FY 2024
Subscription and Circulation
56.4%$4M
Technology Service
27.1%$2M
Health Care, Patient Service
16.5%$1M
WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M
VTRVentas, Inc.
FY 2025
Senior Living Operations
74.0%$4.3B
Outpatient Medical And Research Portfolio
15.5%$898M
Triple Net Leased Properties
10.4%$602M
TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M

VSEEW vs WELL vs VTR vs TDOC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWELLLAGGINGVTR

Income & Cash Flow (Last 12 Months)

Evenly matched — WELL and VTR each lead in 2 of 6 comparable metrics.

WELL is the larger business by revenue, generating $11.6B annually — 799.3x VSEEW's $15M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to VSEEW's -85.8%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVSEEW logoVSEEWVSee Health, Inc.WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.TDOC logoTDOCTeladoc Health, I…
RevenueTrailing 12 months$15M$11.6B$6.1B$2.5B
EBITDAEarnings before interest/tax-$6M$2.8B$2.3B$42M
Net IncomeAfter-tax profit-$12M$1.4B$260M-$171M
Free Cash FlowCash after capex-$5M$2.5B$1.4B$251M
Gross MarginGross profit ÷ Revenue+54.6%+39.1%-4.3%+65.6%
Operating MarginEBIT ÷ Revenue-65.1%+4.4%+13.4%-7.6%
Net MarginNet income ÷ Revenue-85.8%+12.3%+4.2%-6.8%
FCF MarginFCF ÷ Revenue-31.1%+21.9%+22.4%+10.0%
Rev. Growth (YoY)Latest quarter vs prior year+18.7%+40.3%+22.0%-2.5%
EPS Growth (YoY)Latest quarter vs prior year+99.8%+22.5%0.0%+32.1%
Evenly matched — WELL and VTR each lead in 2 of 6 comparable metrics.

Valuation Metrics

TDOC leads this category, winning 4 of 6 comparable metrics.

At 154.4x trailing earnings, WELL trades at a 4% valuation discount to VTR's 161.6x P/E. On an enterprise value basis, TDOC's 15.6x EV/EBITDA is more attractive than WELL's 66.9x.

MetricVSEEW logoVSEEWVSee Health, Inc.WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.TDOC logoTDOCTeladoc Health, I…
Market CapShares × price$544,726$150.4B$41.5B$1.3B
Enterprise ValueMkt cap + debt − cash$10M$166.7B$54.0B$1.6B
Trailing P/EPrice ÷ TTM EPS-0.01x154.41x161.64x-6.36x
Forward P/EPrice ÷ next-FY EPS est.79.65x119.03x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple66.86x24.47x15.65x
Price / SalesMarket cap ÷ Revenue0.05x14.10x7.11x0.52x
Price / BookPrice ÷ Book value/share3.38x3.21x0.92x
Price / FCFMarket cap ÷ FCF52.80x31.52x4.58x
TDOC leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

WELL leads this category, winning 4 of 9 comparable metrics.

WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-12 for TDOC. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs VSEEW's 3/9, reflecting strong financial health.

MetricVSEEW logoVSEEWVSee Health, Inc.WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.TDOC logoTDOCTeladoc Health, I…
ROE (TTM)Return on equity+3.5%+2.1%-12.4%
ROA (TTM)Return on assets-66.7%+2.3%+1.0%-5.9%
ROICReturn on invested capital-15.0%+0.5%+2.5%-11.5%
ROCEReturn on capital employed-63.3%+0.6%+3.2%-10.0%
Piotroski ScoreFundamental quality 0–93766
Debt / EquityFinancial leverage0.49x1.05x0.75x
Net DebtTotal debt minus cash$9M$16.3B$12.5B$259M
Cash & Equiv.Liquid assets$326,115$5.0B$741M$781M
Total DebtShort + long-term debt$10M$21.4B$13.2B$1.0B
Interest CoverageEBIT ÷ Interest expense-5.77x0.26x1.40x-8.76x
WELL leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,610 today (with dividends reinvested), compared to $514 for TDOC. Over the past 12 months, WELL leads with a +46.7% total return vs VSEEW's -8.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.9% vs TDOC's -34.7% — a key indicator of consistent wealth creation.

MetricVSEEW logoVSEEWVSee Health, Inc.WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.TDOC logoTDOCTeladoc Health, I…
YTD ReturnYear-to-date-65.4%+15.2%+13.5%+2.8%
1-Year ReturnPast 12 months-8.8%+46.7%+36.1%+2.4%
3-Year ReturnCumulative with dividends-68.0%+191.6%+95.8%-72.2%
5-Year ReturnCumulative with dividends-68.0%+206.1%+75.6%-94.9%
10-Year ReturnCumulative with dividends-68.0%+225.2%+66.1%-38.7%
CAGR (3Y)Annualised 3-year return-31.6%+42.9%+25.1%-34.7%
WELL leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — VSEEW and VTR each lead in 1 of 2 comparable metrics.

VSEEW is the less volatile stock with a -0.31 beta — it tends to amplify market swings less than TDOC's 1.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 98.6% from its 52-week high vs VSEEW's 12.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVSEEW logoVSEEWVSee Health, Inc.WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.TDOC logoTDOCTeladoc Health, I…
Beta (5Y)Sensitivity to S&P 500-0.31x0.15x-0.01x1.89x
52-Week HighHighest price in past year$0.26$219.59$88.50$9.77
52-Week LowLowest price in past year$0.01$142.65$61.76$4.40
% of 52W HighCurrent price vs 52-week peak+12.3%+97.7%+98.6%+74.2%
RSI (14)Momentum oscillator 0–10042.954.555.876.1
Avg Volume (50D)Average daily shares traded2K2.6M3.5M5.2M
Evenly matched — VSEEW and VTR each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — WELL and VTR each lead in 1 of 2 comparable metrics.

Analyst consensus: WELL as "Buy", VTR as "Buy", TDOC as "Hold". Consensus price targets imply 8.7% upside for WELL (target: $233) vs 4.6% for TDOC (target: $8). For income investors, VTR offers the higher dividend yield at 2.13% vs WELL's 1.29%.

MetricVSEEW logoVSEEWVSee Health, Inc.WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.TDOC logoTDOCTeladoc Health, I…
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$233.25$93.91$7.58
# AnalystsCovering analysts343242
Dividend YieldAnnual dividend ÷ price+1.3%+2.1%
Dividend StreakConsecutive years of raises21
Dividend / ShareAnnual DPS$2.76$1.86
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%
Evenly matched — WELL and VTR each lead in 1 of 2 comparable metrics.
Key Takeaway

WELL leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). TDOC leads in 1 (Valuation Metrics). 3 tied.

Best OverallWelltower Inc. (WELL)Leads 2 of 6 categories
Loading custom metrics...

VSEEW vs WELL vs VTR vs TDOC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VSEEW or WELL or VTR or TDOC a better buy right now?

For growth investors, VSee Health, Inc.

(VSEEW) is the stronger pick with 78. 4% revenue growth year-over-year, versus -1. 5% for Teladoc Health, Inc. (TDOC). Welltower Inc. (WELL) offers the better valuation at 154. 4x trailing P/E (79. 6x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VSEEW or WELL or VTR or TDOC?

On trailing P/E, Welltower Inc.

(WELL) is the cheapest at 154. 4x versus Ventas, Inc. at 161. 6x. On forward P/E, Welltower Inc. is actually cheaper at 79. 6x.

03

Which is the better long-term investment — VSEEW or WELL or VTR or TDOC?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +206. 1%, compared to -94. 9% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: WELL returned +225. 2% versus VSEEW's -68. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VSEEW or WELL or VTR or TDOC?

By beta (market sensitivity over 5 years), VSee Health, Inc.

(VSEEW) is the lower-risk stock at -0. 31β versus Teladoc Health, Inc. 's 1. 89β — meaning TDOC is approximately -711% more volatile than VSEEW relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VSEEW or WELL or VTR or TDOC?

By revenue growth (latest reported year), VSee Health, Inc.

(VSEEW) is pulling ahead at 78. 4% versus -1. 5% for Teladoc Health, Inc. (TDOC). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -572. 6% for VSee Health, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VSEEW or WELL or VTR or TDOC?

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus -553. 7% for VSee Health, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTR leads at 14. 2% versus -596. 4% for VSEEW. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VSEEW or WELL or VTR or TDOC more undervalued right now?

On forward earnings alone, Welltower Inc.

(WELL) trades at 79. 6x forward P/E versus 119. 0x for Ventas, Inc. — 39. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 8. 7% to $233. 25.

08

Which pays a better dividend — VSEEW or WELL or VTR or TDOC?

In this comparison, VTR (2.

1% yield), WELL (1. 3% yield) pay a dividend. VSEEW, TDOC do not pay a meaningful dividend and should not be held primarily for income.

09

Is VSEEW or WELL or VTR or TDOC better for a retirement portfolio?

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 01), 2. 1% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VTR: +66. 1%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VSEEW and WELL and VTR and TDOC?

These companies operate in different sectors (VSEEW (Healthcare) and WELL (Real Estate) and VTR (Real Estate) and TDOC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VSEEW is a small-cap high-growth stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; TDOC is a small-cap quality compounder stock. WELL, VTR pay a dividend while VSEEW, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

VSEEW

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 32%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Stocks Like

VTR

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

TDOC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 39%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform VSEEW and WELL and VTR and TDOC on the metrics below

Revenue Growth>
%
(VSEEW: 18.7% · WELL: 40.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.